Pacific Biosciences enters agreement for up to $100 million at-the-market share offering
PACB•Pacific Biosciences signed a sales agreement on November 10 for an at-the-market offering of up to $100 million in common stock. Allen & Company will receive up to 3% of gross proceeds from shares it sells.
